Latin America Lung Cancer Surgery Market

Latin America Lung Cancer Surgery Market Size (2024 to 2029)

The Lung Cancer Surgery Market size in Latin America had a market value of USD 5.42 billion in 2024 and is forecasted to exhibit a CAGR of 8.1% and worth USD 7.99 billion by 2029.

Cancer name is generally given by the name of the organ in which it starts. Lung Cancer is a type of cancer that starts in Lung tissue or its surrounding parts. There are various treatments available to treat lung cancer, like Chemotherapy, Radiotherapy, Laser Therapy, and Surgery. Surgery involves removing infected sections from the lung, and in some cases, a complete lung is removed. However, Surgery couldn’t be used if cancer cells are close to the heart.

Increasing pollution levels, rising number of cigarette smokers, rising incidence and prevalence of Lung Cancer, and rising geriatric population are major factors driving the market.

However, the high cost of Lung Cancer surgery is restraining the growth of the market.

This research report on the Latin American Lung Cancer Surgery Market has been segmented & sub-segmented into the following categories.

Latin America Lung Cancer Surgery Market  By Procedure

• Thoracotomy
  • Lobectomy
  • Pneumonectomy
  • Sleeve Resection
  • Segmentectomy
• Minimally Invasive

Latin America Lung Cancer Surgery Market By Device

• Surgical
  • Clamps
  • Forceps
  • Retractors
  • Staplers
  • Cutters
  • Scissors
  • Elevators
  • RIB Sheers
  • Trocars
• Monitoring
  • Cameras
  • Video Support
• Visualizing Systems
  • Endoscopic Trocars with Optical Views
  • Endo Surgical Equipment

Latin America Lung Cancer Surgery Market By Country

• Mexico
• Brazil
• Argentina
• Chile
• Rest of Latin America

Based on procedure, Minimally Invasive surgeries are expected to grow at the highest CAGR owing to the rising awareness among people for early detection of lung cancer and the advantages of Minimally Invasive Surgeries over conventional surgeries.

Based on the device, the Surgical Instruments segment is expected to dominate the market due to the shorter lifespan of devices and the wider adoption.

Geographically, the Latin American market is expected to show significant growth during the forecast period due to increasing disposable incomes and improving healthcare facilities. 

Prominent companies operating in the LATAM Lung Cancer Surgery Market include Ethicon US LLC, Intuitive Surgical Inc., AngioDynamics Inc., Olympus Corporation, Accuray Inc., Ackermann Instrumente GmbH, Teleflex Inc., KARL STORZ GmbH, Scanlan International Inc., and Trokamed GmbH.